
Senseonics Holdings (SENS) Stock Forecast & Price Target
Senseonics Holdings (SENS) Analyst Ratings
Bulls say
Senseonics Holdings Inc. is projected to achieve total revenues of $75.6 million in 2026 and $118.4 million in 2027, demonstrating significant growth from prior financial forecasts. The company's gross margins are anticipated to surpass 50% by the end of next year, reflecting an upward trend from 43% in Q3, which is an improvement from 36% in the first half of 2025. Additionally, the company has experienced a remarkable 90% year-over-year increase in topline revenue, driven by a substantial influx of new patients transitioning to the Eversense 365 glucose monitoring system.
Bears say
Senseonics Holdings Inc. has projected that its revenues for the first half of 2025 will remain relatively flat, largely due to the conversion of previous U.S. operations, which raises concerns about its growth prospects in a competitive market. Despite reporting quarterly revenues of $8.1 million, slightly exceeding consensus estimates, the company also posted a net loss of $0.43 per share, which was greater than the expected net loss of $0.40 per share. This combination of stagnant revenue expectations and increasing losses highlights the financial challenges the company faces, contributing to a negative outlook on its stock performance.
This aggregate rating is based on analysts' research of Senseonics Holdings and is not a guaranteed prediction by Public.com or investment advice.
Senseonics Holdings (SENS) Analyst Forecast & Price Prediction
Start investing in Senseonics Holdings (SENS)
Order type
Buy in
Order amount
Est. shares
0 shares